Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
Kairos Pharma Closing of $6.2 Million Initial Public Offering
Kairos Pharma Prices $6.2 Million Initial Public Offering [Yahoo! Finance]
Kairos Pharma Prices $6.2 Million Initial Public Offering